Back to Search
Start Over
Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma
- Source :
- Leukemia & Lymphoma. 61:2985-2989
- Publication Year :
- 2020
- Publisher :
- Informa UK Limited, 2020.
-
Abstract
- Histologic transformation of indolent lymphomas account for 13% of de novo presentations of diffuse large B-cell lymphoma (DLBCL) [1]. Although historically associated with poor outcomes in compari...
- Subjects :
- Cancer Research
business.industry
Extramural
Hematology
medicine.disease
Lymphoma
03 medical and health sciences
0302 clinical medicine
Oncology
immune system diseases
hemic and lymphatic diseases
030220 oncology & carcinogenesis
Cancer research
Medicine
In patient
Rituximab
business
Indolent lymphomas
B-cell lymphoma
030215 immunology
medicine.drug
Subjects
Details
- ISSN :
- 10292403 and 10428194
- Volume :
- 61
- Database :
- OpenAIRE
- Journal :
- Leukemia & Lymphoma
- Accession number :
- edsair.doi...........e0d254c25adc642f20adbc8c36d6c5f4